Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 85
Central Nervous System Drugs 56
Endocrine and Metabolic Disorders Drugs 50
Drug Discovery 31
Musculoskeletal Disorders Drugs 26
Infusions and Injectables 25
Surgical Procedures 19
Pharmaceuticals 18
Biopharmaceuticals 15
Prostate Cancer Drugs 13
Drug Delivery 13
Clinical Trials 12
Women's Health 11
Dermatology 10
Pancreatic Cancer Drugs 10
Neurology 9
Liver Cancer Drugs 9
Oncology 9
Biotechnology 7
Healthcare Services 7
Lung Cancer Drugs 7
Medical Devices 7
Immune Disorders Drugs 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Sexual and Reproductive Health Drugs 6
Company Reports 5
Breast Cancer Drugs 5
Genomics 5
Thyroid Cancer Drugs 5
Urology and Nephrology 4
Ovarian Cancer Drugs 4
Brain Cancer Drugs 4
Enzymes 4
Over the Counter (OTC) Drugs 4
Dermatological Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Colon Cancer Drugs 3
Bladder Cancer Drugs 3
Managed Care 3
Kidney Cancer Drugs 3
Pediatrics 3
Gastroenterology 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Needles and Syringes 2
Hematology 2
Surgical Devices 2
Biosimilars and Biosuperiors 2
Nanomedicine 2
Urological Disorders Drugs 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Pharmacoeconomics 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Healthcare 1
Transdermal and Transmucosal Drug Delivery 1
Hematological Drugs 1
Nuclear Medicine and Radiopharmacology 1
Skin Cancer Drugs 1
Other Healthcare Facilities 1
Laboratory Equipment 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Alzheimer's Disease Drugs 1
Pharmaceutical Manufacturing 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

442 Results (Page 15 of 23)
- Relevance
  Sort by

Skin Boosters - Global Strategic Business Report

 Report
July 2025
470 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Rare Endocrine Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
105 Pages
Global

From

€3500EUR$4,267USD£3,125GBP

Adrenocorticotropic Hormone Receptor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
79 Pages
Global

From

€3500EUR$4,267USD£3,125GBP

Glioma Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

BCL-2 b-Cell Lymphoma 2 Inhibitors - Global Strategic Business Report

 Report
July 2025
204 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Lung Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Biosimilar Therapeutic Peptides Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Targeted Liposomes Drug Delivery - Global Strategic Business Report

 Report
July 2025
181 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Liposome Development and Liposome Manufacturing Services Market, 2022-2035: Distribution by Type of Product Formulation, Scale of Operation, End User Industry, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
December 2022
226 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

Liposome Drug Delivery - Global Strategic Business Report

 Report
July 2025
576 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

United Kingdom Prostate Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
81 Pages
United Kingdom

From

€2614EUR$2,975USD£2,255GBP

€3075EUR$3,500USD£2,653GBP

Small Cell Lung Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
100 Pages
Global

From

€2636EUR$3,000USD£2,274GBP

Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1318EUR$1,500USD£1,137GBP

Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - Distribution by Target Indications, Key Players and Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
140 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

Pituitary Cancer - Global Strategic Business Report

 Report
July 2025
575 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Esophageal Squamous Cell Carcinoma - Global Strategic Business Report

 Report
July 2025
275 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Diffuse Large B-Cell Lymphoma Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Follicular Lymphoma Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Primary Biliary Cholangitis Therapeutics - Global Strategic Business Report

 Report
July 2025
273 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

 Report
February 2022
421 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

442 Results (Page 15 of 23)
- 1
- 13
- 14
- 15
- 16
- 17

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.